Close Menu

biochips

NEW YORK (GenomeWeb) – New molecular diagnostics platform firm InSilixa has completed a $13 million private financing round.

Fluidigm of South San Francisco, Calif., has received US Patent No.

By Justin Petrone
The Singapore Institute of Manufacturing Technology has established a new resource to help companies develop microfluidic devices, including biochips.

Companies developing array- or biochip-based molecular diagnostics received a shot in the arm earlier this month under the Internal Revenue Service's $1 billion Qualifying Therapeutic Discovery Project program.

While the majority of the new funding will support genome-wide association studies, also benefiting from the federal stimulus package are research projects focused on copy number-variation analysis, gene expression, and bioinformatics.

Released this week as a product and a service that uses either catalog or custom arrays, HybSelect initially targets users of the Illumina Genome Analyzer who want to sequence up to 9.5 megabases of genomic DNA.

The company is looking to differentiate itself from other players in the miRNA array market — such as Agilent Technologies, Life Technologies, Exiqon, and Febit — by stressing the "quality, performance, and affordability" of its OneArray platform.

New Product Watch: Mar 10, 2009

Premium

Febit, DNAStar, Premier Biosoft

Febit plans to debut the method at Cambridge Healthtech Institute's Next-Generation Sequencing conference in San Diego next month.

Funding Update for Feb 12, 2009

Premium

Recent NSF Awards in Proteomics and Protein Research

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.